N.J. should be more ‘pro’ about antibody treatments | Letters
Updated Jan 24, 2021;
Facebook Share
Hospitals are in danger of reaching capacity if the COVID-19 pandemic worsens. The U.S. Food and Drug Administration has approved monoclonal antibodies as an early and very effective treatment, but far too few Americans and New Jerseyans are receiving this medication or are aware it exists.
The most vulnerable who qualify for the medical combination may avoid hospitalization by receiving this treatment. It must be more accessible for everyone. It will save lives.
President Joe Biden is finally in office and state Commissioner of Human Services Carole Johnson and Consumer Affairs Director Paul Rodríguez were appointed to critical positions in his administration. The president is committed to mask wearing and has declared a mission to distribute the vaccine swiftly. The New Jersey officials appointed to the Biden administration and Gov. Phil Murphy are at the forefront of this process to save lives.